Mustang Bio

$3.05
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.12 (-3.79%) Today
$0.00 (0.00%) As of 12:00 AM UTC after-hours

Why Robinhood?

You can buy or sell Mustang Bio and other stocks, options, and ETFs commission-free!

About MBIO

Mustang Bio, Inc. Common Stock, also called Mustang Bio, is a clinical-stage biopharmaceutical company that focuses on the development and commercialization of a broad range of proprietary chimeric antigen receptor engineered T cell (CAR T) immunotherapies and gene therapies.

CEO
Manuel Litchman
Employees
62
Headquarters
Worcester, Massachusetts
Founded
2015
Market Cap
258.14M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
1.67M
High Today
$3.16
Low Today
$2.98
Open Price
$3.16
Volume
1.60M
52 Week High
$5.22
52 Week Low
$2.42

MBIO Earnings

-$0.42
-$0.28
-$0.14
-$0.00
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Estimated
— per share
Actual
Expected May 10, After Hours

You May Also Like

FFHG
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure